期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抑肽酶致过敏性休克的文献分析 被引量：2

暂未订购
导出
摘要 目的:调查了解抑肽酶致过敏性休克的情况及相关因素,为临床安全、有效、合理用药提供信息。方法:对国内近10年公开发表的有关应用抑肽酶出现过敏性休克的病例报告进行分析整理。结果:抑肽酶致过敏性休克发生迅速、反应重、病情变化快、危险性大,多数在用药后5min内发生。结论:应充分认识和掌握抑肽酶注射剂致过敏性休克的特点,加强用药期间的观察与监测;建议使用前作静脉过敏试验,且不宜与其他药物配伍。
作者 李文杰 刘顺良 李慧
机构地区 中国人民解放军第
出处 《中国药业》 CAS 2006年第1期56-57,共2页 China Pharmaceuticals
关键词 抑肽酶 过敏性休克 安全用药
分类号 R969.3 [医药卫生—药理学] R973.1 [医药卫生—药品]
  • 相关文献

参考文献12

二级参考文献24

  • 1[1]Fritz H, Wunderer G. Biochemistry and applications of approtinin, the kallikrein inhibitor from boving organs[J]. Arzneimittelforschung, 1983,33(4) :479 - 494.
  • 2[2]Miller BE, Tosone SR, Tam VKH, et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operation[ J] .Ann Thorac Surg, 1998,66(3):535 - 540.
  • 3[3]Porte R J, Molenaar IQ, Begliomini B. Aprotinin and transfusion requirement in orthotopic liver transplantation: a multicentre randomized double-blind study [ J ]. Lancet, 2000,355(9 212): 1 303 - 1 309.
  • 4[4]Asimakopoulos G, Thompson R, Nourshargh S, et al. An antiinflammatory property of aprotinin detected at the level of leukocyte extravasation [J]. J Thorac Cardiovasc Surg, 2000,120(2) :361 - 369.
  • 5[5]Martinowitz U, Spotnitz WD. Fibrin tissue adhensive [J].Thromb Haemost, 1997,78(1) :661 - 666.
  • 6[6]Davidson BR, Burnett S, Javed MS, et al. Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy[ J]. Br J Surg, 2000,87(6) :790 - 795.
  • 7[7]Born P, Ott R, Rosch T. Endoscopic hemostasis using fibrin sealant for postsphinct erotomy bleeding: report of two case [ J ]. Gastrointest Endosc, 2000,51 (6): 731 - 733.
  • 8[8]Holcomb JB, McClain JM, Pusateri AE, et al. Fibrin sealant foam sprayed directlyon liver injuries decrease blood loss in resuscitated rats[J] .J Trauma,2000,49(2):246- 250.
  • 9[9]Scheule AM, Jurmann MJ, Wended HP, et al. Anaphylactic shock after aprotinin reexposure: time course of aprotinin-specific antibodies[J]. Ann Thorac Surg, 1997,63 (3): 242 -244.
  • 10[10]Scheule AM, Beierlein W, Lorenz H, et al. Repeated anaphylactic reaction to aprotinin in fibrin sealant [J]. Gastrointest Endosc, 1998,48( 1 ) :83 - 85.

共引文献19

同被引文献22

  • 1陈杰,陶国才.抑肽酶过敏反应[J].免疫学杂志,2001,17(z1):154-156. 被引量：6
  • 2曾金,李萍萍,黄一丹.心脏直视手术中抑肽酶过敏性休克2例[J].江西医药,2006,41(11):861-862. 被引量：1
  • 3Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management : an attempt at consensus [ J ]. Gastrointest Endosc, 1991, 37(3) :383 -393.
  • 4Russo MW, Wei JT, Thiny MT, et al. Digestive and liver diseases statistics, 2004 [ J ]. Gastroenterology, 2004, 126 ( 5 ): 1448 - 1453.
  • 5Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis : a prospective muhicentcr study [ J ]. Am J Gastroenterol, 2006, 101 ( 1 ) :1349 - 1347.
  • 6Tsujino T, Kawabe T, Omata M. Antiproteases in preventing post- ERCP acute pancreatitis [ J ]. JOP, 2007, 8 (4) :509 - 517.
  • 7Granger J, Remick D. Acute pancreatitis: models, markers, and mediators[J]. Shock, 2005, 24( 1 ) :45 -51.
  • 8Chen CC, Wang SS, Lu RH, et al. Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography[J]. Pancreas, 2003, 26 ( 4 ) : 375 - 380.
  • 9Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis [ J ]. Gastrointest Endosc, 2000, 51 ( 1 ) : 1 - 7.
  • 10Andriulli A, Clemente R, Sohni L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a muhicenter, placebo-controlled, randomized clinical trial[J]. Gastrointest Endose, 2002, 56(4) :488 -495.

引证文献2

中国药业
2006年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部